Metraipolis › archive › dc_f37e7c3161cc
Predicting Immunotherapy Outcomes in NSCLC Using RNA and Pathology from Multicenter Clinical Trials — Europe PMC PMID:41159493
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41159493
- DOI
- 10.1002/advs.202502037
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T23:40:36.694Z
- SHA-256 of the archived text
ff4fac8840cbc2d564e64687ae037368ddde6cd895e4f98bb8b658abf50cb74f- Stable URL of this page
https://metraipolis.com/documento/dc_f37e7c3161cc
How to cite
Predicting Immunotherapy Outcomes in NSCLC Using RNA and Pathology from Multicenter Clinical Trials — Europe PMC PMID:41159493 — Europe PMC (en), https://europepmc.org/article/MED/41159493 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f37e7c3161cc (Metraipolis archive dc_f37e7c3161cc, sha256 ff4fac8840cbc2d564e64687ae037368ddde6cd895e4f98bb8b658abf50cb74f)
BibTeX
@misc{dcf37e7c3161cc,
title = {Predicting Immunotherapy Outcomes in NSCLC Using RNA and Pathology from Multicenter Clinical Trials — Europe PMC PMID:41159493},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41159493},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f37e7c3161cc; sha256 ff4fac8840cbc2d564e64687ae037368ddde6cd895e4f98bb8b658abf50cb74f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41159493. Agents can read the archived copy with the MCP tool read_document.